Compile Data Set for Download or QSAR
Report error Found 11 Enz. Inhib. hit(s) with all data for entry = 5997
Target3-phosphoinositide-dependent protein kinase 1(Human)
International Society For Drug Development

US Patent
LigandPNGBDBM405822(US10351548, Compound IB36)
Affinity DataIC50: 19nMAssay Description:Factor IX is a key component of the plasma system that forms a fibrin clot at a site of vascular injury. The activity of Factor IXa is measured by mo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2020
Entry Details
Go to US Patent

Target3-phosphoinositide-dependent protein kinase 1(Human)
International Society For Drug Development

US Patent
LigandPNGBDBM405827(US10351548, Compound DD21)
Affinity DataIC50: 103nMAssay Description:Factor IX is a key component of the plasma system that forms a fibrin clot at a site of vascular injury. The activity of Factor IXa is measured by mo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2020
Entry Details
Go to US Patent

Target3-phosphoinositide-dependent protein kinase 1(Human)
International Society For Drug Development

US Patent
LigandPNGBDBM50185001(CHEMBL3824119 | US10351548, Compound IB35)
Affinity DataIC50: 112nMAssay Description:Factor IX is a key component of the plasma system that forms a fibrin clot at a site of vascular injury. The activity of Factor IXa is measured by mo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2020
Entry Details
Go to US Patent

Target3-phosphoinositide-dependent protein kinase 1(Human)
International Society For Drug Development

US Patent
LigandPNGBDBM405828(US10351548, Compound DD40)
Affinity DataIC50: 245nMAssay Description:Factor IX is a key component of the plasma system that forms a fibrin clot at a site of vascular injury. The activity of Factor IXa is measured by mo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2020
Entry Details
Go to US Patent

Target3-phosphoinositide-dependent protein kinase 1(Human)
International Society For Drug Development

US Patent
LigandPNGBDBM405829(US10351548, Compound DF8)
Affinity DataIC50: 245nMAssay Description:Factor IX is a key component of the plasma system that forms a fibrin clot at a site of vascular injury. The activity of Factor IXa is measured by mo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2020
Entry Details
Go to US Patent

Target3-phosphoinositide-dependent protein kinase 1(Human)
International Society For Drug Development

US Patent
LigandPNGBDBM50185000(CHEMBL3823844 | US10351548, Compound SA16)
Affinity DataIC50: 416nMAssay Description:Factor IX is a key component of the plasma system that forms a fibrin clot at a site of vascular injury. The activity of Factor IXa is measured by mo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2020
Entry Details
Go to US Patent

Target3-phosphoinositide-dependent protein kinase 1(Human)
International Society For Drug Development

US Patent
LigandPNGBDBM50185003(CHEMBL3824264 | US10351548, Compound JJ31)
Affinity DataIC50: 512nMAssay Description:Factor IX is a key component of the plasma system that forms a fibrin clot at a site of vascular injury. The activity of Factor IXa is measured by mo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2020
Entry Details
Go to US Patent

Target3-phosphoinositide-dependent protein kinase 1(Human)
International Society For Drug Development

US Patent
LigandPNGBDBM405826(US10351548, Compound DD22)
Affinity DataIC50: 1.34E+3nMAssay Description:Factor IX is a key component of the plasma system that forms a fibrin clot at a site of vascular injury. The activity of Factor IXa is measured by mo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2020
Entry Details
Go to US Patent

Target3-phosphoinositide-dependent protein kinase 1(Human)
International Society For Drug Development

US Patent
LigandPNGBDBM50184999(CHEMBL3823622 | US10351548, Compound SA23)
Affinity DataIC50: 1.52E+3nMAssay Description:Factor IX is a key component of the plasma system that forms a fibrin clot at a site of vascular injury. The activity of Factor IXa is measured by mo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2020
Entry Details
Go to US Patent

Target3-phosphoinositide-dependent protein kinase 1(Human)
International Society For Drug Development

US Patent
LigandPNGBDBM405830(US10351548, Compound DF9)
Affinity DataIC50: 5.88E+3nMAssay Description:Factor IX is a key component of the plasma system that forms a fibrin clot at a site of vascular injury. The activity of Factor IXa is measured by mo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2020
Entry Details
Go to US Patent

Target3-phosphoinositide-dependent protein kinase 1(Human)
International Society For Drug Development

US Patent
LigandPNGBDBM50185002(CHEMBL3822974 | US10351548, Compound IB32)
Affinity DataIC50: 6.68E+3nMAssay Description:Factor IX is a key component of the plasma system that forms a fibrin clot at a site of vascular injury. The activity of Factor IXa is measured by mo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2020
Entry Details
Go to US Patent